In pancreatic ductal adenocarcinoma (PDAC), KRAS mutations in ExoDNA were detected in 43.6% of early PDAC patients and in 20% of healthy controls 76. The gene discussed is KRAS; the disease is pancreatic ductal adenocarcinoma.